Review




Structured Review

ProMIS Neurosciences promis- fatigue short form 7a
Promis Fatigue Short Form 7a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fatigue+short+form+7a/promis+f+sf+7a/pm40574492-211-14-14
Average 90 stars, based on 1 article reviews
promis- fatigue short form 7a - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

Biomarker Discovery:

Article Title: Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
Article Snippet: Fatigue response at Weeks 6 and 12 (based on the PROMIS Fatigue Short Form 7a; to be defined in the SAP).

Article Title: Emotional Awareness and Expression Therapy vs Cognitive Behavioral Therapy for Chronic Pain in Older Veterans
Article Snippet: PROMIS Fatigue Short Form 7a, mean (SD), score , 20.8 (5.4) , 21.4 (5.4).

Article Title: TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy
Article Snippet: Patient-reported outcomes are also being investigated, including time to deterioration (TTD; defined as the time from the date of randomization to the date of deterioration) in physical function assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Short Form 8c; , TTD in Global Health State (GHS)/Quality of Life (QoL) measured by the European Organisation for Research and Treatment of Cancer (EORTC) IL172 scale, which comprises 12 items for the GHS/QoL and role, emotional, cognitive, and social function scales from the EORTC QLQ-C30; and fatigue measured via the PROMIS Fatigue Short Form 7a., Safety and tolerability of Dato-DXd with or without durvalumab relative to ICT will be assessed in terms of adverse events (AEs) graded by Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 (v5.0), ECOG PS, clinical examination, and laboratory assessment.

Article Title: Interventions for Long COVID: A Narrative Review.
Article Snippet: Long COVID continues to impose a significant burden on COVID-19 survivors, presenting with diverse symptoms and clinical uncertainty.. This review synthesized evidence from 97 studies, including 26 randomized controlled trials and 15 non-randomized comparative studies, which explored the effectiveness, comparative effectiveness, and potential risks of proposed interventions for managing common long COVID symptoms: fatigue, neurocognitive symptoms, anxiety, depression, and sleep issues.. Our comprehensive analysis, encompassing English-language articles, gray literature, and feedback from 14 Key Informants (i.e., patients, caregivers, clinicians, payors, and researchers), reveals a persistently weak body of evidence, characterized by high imprecision and considerable uncertainty regarding the benefits and harms of the interventions.

Article Title: Comparative efficacy of traditional non-pharmacological add-on treatments in patients with stable chronic obstructive pulmonary disease: a systematic review and network meta-analysis
Article Snippet: , , Yeh, Litrownik, Wayne, Beach, Klings, Reyes Nieva, Pinheiro, Davis, and Moy (2020)/USA, Boston ( ) , RCT , Stable COPD , 52 , Tai chi , HRQL (CRQ, UCSDSOB), CSES, CES-D, Multidimensional Scale of Perceived Social Support, 6MWD, Chair Stand test, Chair sit and reach test, PROMIS Fatigue Short Form 7a, CHAMPS , 19 “A total of 19 reportable adverse events occurred during the 12- week intervention period (16 in TC, 3 in education).” [9 COPD exacerbations, 4 musculoskeletal flares].

Article Title: Prevalence and Factors Associated with High Impact Chronic Pain in Knee Osteoarthritis: the Johnston County Health Study
Article Snippet: 32 For the current analysis, we used the PROMIS Anxiety Short Form 7a (7 items), Depression Short Form 8b (8 items), Fatigue Short Form 7a (7 items), and Sleep Disturbance Short Form 8b (8 items), Physical Function Short Form 10a (10 items), and Pain Interference Short Form 6b (6 items).

Medications:

Article Title: Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
Article Snippet: Fatigue response at Weeks 6 and 12 (based on the PROMIS Fatigue Short Form 7a; to be defined in the SAP).

Article Title: Emotional Awareness and Expression Therapy vs Cognitive Behavioral Therapy for Chronic Pain in Older Veterans
Article Snippet: PROMIS Fatigue Short Form 7a, mean (SD), score , 20.8 (5.4) , 21.4 (5.4).

Article Title: TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy
Article Snippet: Patient-reported outcomes are also being investigated, including time to deterioration (TTD; defined as the time from the date of randomization to the date of deterioration) in physical function assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Short Form 8c; , TTD in Global Health State (GHS)/Quality of Life (QoL) measured by the European Organisation for Research and Treatment of Cancer (EORTC) IL172 scale, which comprises 12 items for the GHS/QoL and role, emotional, cognitive, and social function scales from the EORTC QLQ-C30; and fatigue measured via the PROMIS Fatigue Short Form 7a., Safety and tolerability of Dato-DXd with or without durvalumab relative to ICT will be assessed in terms of adverse events (AEs) graded by Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 (v5.0), ECOG PS, clinical examination, and laboratory assessment.

Article Title: Interventions for Long COVID: A Narrative Review.
Article Snippet: Long COVID continues to impose a significant burden on COVID-19 survivors, presenting with diverse symptoms and clinical uncertainty.. This review synthesized evidence from 97 studies, including 26 randomized controlled trials and 15 non-randomized comparative studies, which explored the effectiveness, comparative effectiveness, and potential risks of proposed interventions for managing common long COVID symptoms: fatigue, neurocognitive symptoms, anxiety, depression, and sleep issues.. Our comprehensive analysis, encompassing English-language articles, gray literature, and feedback from 14 Key Informants (i.e., patients, caregivers, clinicians, payors, and researchers), reveals a persistently weak body of evidence, characterized by high imprecision and considerable uncertainty regarding the benefits and harms of the interventions.

Article Title: Comparative efficacy of traditional non-pharmacological add-on treatments in patients with stable chronic obstructive pulmonary disease: a systematic review and network meta-analysis
Article Snippet: , , Yeh, Litrownik, Wayne, Beach, Klings, Reyes Nieva, Pinheiro, Davis, and Moy (2020)/USA, Boston ( ) , RCT , Stable COPD , 52 , Tai chi , HRQL (CRQ, UCSDSOB), CSES, CES-D, Multidimensional Scale of Perceived Social Support, 6MWD, Chair Stand test, Chair sit and reach test, PROMIS Fatigue Short Form 7a, CHAMPS , 19 “A total of 19 reportable adverse events occurred during the 12- week intervention period (16 in TC, 3 in education).” [9 COPD exacerbations, 4 musculoskeletal flares].

Article Title: Prevalence and Factors Associated with High Impact Chronic Pain in Knee Osteoarthritis: the Johnston County Health Study
Article Snippet: 32 For the current analysis, we used the PROMIS Anxiety Short Form 7a (7 items), Depression Short Form 8b (8 items), Fatigue Short Form 7a (7 items), and Sleep Disturbance Short Form 8b (8 items), Physical Function Short Form 10a (10 items), and Pain Interference Short Form 6b (6 items).

Comparison:

Article Title: Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
Article Snippet: Fatigue response at Weeks 6 and 12 (based on the PROMIS Fatigue Short Form 7a; to be defined in the SAP).

Article Title: Emotional Awareness and Expression Therapy vs Cognitive Behavioral Therapy for Chronic Pain in Older Veterans
Article Snippet: PROMIS Fatigue Short Form 7a, mean (SD), score , 20.8 (5.4) , 21.4 (5.4).

Article Title: TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy
Article Snippet: Patient-reported outcomes are also being investigated, including time to deterioration (TTD; defined as the time from the date of randomization to the date of deterioration) in physical function assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Short Form 8c; , TTD in Global Health State (GHS)/Quality of Life (QoL) measured by the European Organisation for Research and Treatment of Cancer (EORTC) IL172 scale, which comprises 12 items for the GHS/QoL and role, emotional, cognitive, and social function scales from the EORTC QLQ-C30; and fatigue measured via the PROMIS Fatigue Short Form 7a., Safety and tolerability of Dato-DXd with or without durvalumab relative to ICT will be assessed in terms of adverse events (AEs) graded by Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 (v5.0), ECOG PS, clinical examination, and laboratory assessment.

Article Title: Interventions for Long COVID: A Narrative Review.
Article Snippet: Long COVID continues to impose a significant burden on COVID-19 survivors, presenting with diverse symptoms and clinical uncertainty.. This review synthesized evidence from 97 studies, including 26 randomized controlled trials and 15 non-randomized comparative studies, which explored the effectiveness, comparative effectiveness, and potential risks of proposed interventions for managing common long COVID symptoms: fatigue, neurocognitive symptoms, anxiety, depression, and sleep issues.. Our comprehensive analysis, encompassing English-language articles, gray literature, and feedback from 14 Key Informants (i.e., patients, caregivers, clinicians, payors, and researchers), reveals a persistently weak body of evidence, characterized by high imprecision and considerable uncertainty regarding the benefits and harms of the interventions.

Article Title: Comparative efficacy of traditional non-pharmacological add-on treatments in patients with stable chronic obstructive pulmonary disease: a systematic review and network meta-analysis
Article Snippet: , , Yeh, Litrownik, Wayne, Beach, Klings, Reyes Nieva, Pinheiro, Davis, and Moy (2020)/USA, Boston ( ) , RCT , Stable COPD , 52 , Tai chi , HRQL (CRQ, UCSDSOB), CSES, CES-D, Multidimensional Scale of Perceived Social Support, 6MWD, Chair Stand test, Chair sit and reach test, PROMIS Fatigue Short Form 7a, CHAMPS , 19 “A total of 19 reportable adverse events occurred during the 12- week intervention period (16 in TC, 3 in education).” [9 COPD exacerbations, 4 musculoskeletal flares].

Article Title: Prevalence and Factors Associated with High Impact Chronic Pain in Knee Osteoarthritis: the Johnston County Health Study
Article Snippet: 32 For the current analysis, we used the PROMIS Anxiety Short Form 7a (7 items), Depression Short Form 8b (8 items), Fatigue Short Form 7a (7 items), and Sleep Disturbance Short Form 8b (8 items), Physical Function Short Form 10a (10 items), and Pain Interference Short Form 6b (6 items).



Similar Products

90
ProMIS Neurosciences promis- fatigue short form 7a
Promis Fatigue Short Form 7a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fatigue+short+form+7a/promis+f+sf+7a/pm40574492-211-14-14
Average 90 stars, based on 1 article reviews
promis- fatigue short form 7a - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
ProMIS Neurosciences patient- reported outcomes measurement information system fatigue short form 7a
Patient Reported Outcomes Measurement Information System Fatigue Short Form 7a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fatigue+short+form+7a/promis+f+sf+7a/pm40574492-55-14-22
Average 90 stars, based on 1 article reviews
patient- reported outcomes measurement information system fatigue short form 7a - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
ProMIS Neurosciences patient-reported outcomes measurement information system fatigue severity short form 7a v1.0 score
Items included in the (A) patient and (B) caregiver models. CS, clinical summary; HADS-A, Hospital Anxiety and Depression Scale anxiety; HADS-D, Hospital Anxiety and Depression Scale depression; KCCQ, Kansas City Cardiomyopathy Questionnaire; MCS, mental component summary; NYHA, New York Heart Association; OS, overall summary; PCS, physical component summary; PROMIS, Patient-Reported <t>Outcomes</t> <t>Measurement</t> <t>Information</t> <t>System;</t> SF-12; 12-item Short Form Health Survey; TS, total symptoms; ZBI, Zarit Burden Interview.
Patient Reported Outcomes Measurement Information System Fatigue Severity Short Form 7a V1.0 Score, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fatigue+short+form+7a/promis+f+sf+7a/pmc12183217-86-68-72
Average 90 stars, based on 1 article reviews
patient-reported outcomes measurement information system fatigue severity short form 7a v1.0 score - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
ProMIS Neurosciences promis-fatigue short form 7a
Items included in the (A) patient and (B) caregiver models. CS, clinical summary; HADS-A, Hospital Anxiety and Depression Scale anxiety; HADS-D, Hospital Anxiety and Depression Scale depression; KCCQ, Kansas City Cardiomyopathy Questionnaire; MCS, mental component summary; NYHA, New York Heart Association; OS, overall summary; PCS, physical component summary; PROMIS, Patient-Reported <t>Outcomes</t> <t>Measurement</t> <t>Information</t> <t>System;</t> SF-12; 12-item Short Form Health Survey; TS, total symptoms; ZBI, Zarit Burden Interview.
Promis Fatigue Short Form 7a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fatigue+short+form+7a/promis+f+sf+7a/pmc12118493-172-2-7
Average 90 stars, based on 1 article reviews
promis-fatigue short form 7a - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
ProMIS Neurosciences promis® short form v1.0-fatigue 7a
Items included in the (A) patient and (B) caregiver models. CS, clinical summary; HADS-A, Hospital Anxiety and Depression Scale anxiety; HADS-D, Hospital Anxiety and Depression Scale depression; KCCQ, Kansas City Cardiomyopathy Questionnaire; MCS, mental component summary; NYHA, New York Heart Association; OS, overall summary; PCS, physical component summary; PROMIS, Patient-Reported <t>Outcomes</t> <t>Measurement</t> <t>Information</t> <t>System;</t> SF-12; 12-item Short Form Health Survey; TS, total symptoms; ZBI, Zarit Burden Interview.
Promis® Short Form V1.0 Fatigue 7a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fatigue+short+form+7a/promis+f+sf+7a/pmc12041122-125-2-1
Average 90 stars, based on 1 article reviews
promis® short form v1.0-fatigue 7a - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
ProMIS Neurosciences patient-reported outcomes measurement information system fatigue short form 7a
Items included in the (A) patient and (B) caregiver models. CS, clinical summary; HADS-A, Hospital Anxiety and Depression Scale anxiety; HADS-D, Hospital Anxiety and Depression Scale depression; KCCQ, Kansas City Cardiomyopathy Questionnaire; MCS, mental component summary; NYHA, New York Heart Association; OS, overall summary; PCS, physical component summary; PROMIS, Patient-Reported <t>Outcomes</t> <t>Measurement</t> <t>Information</t> <t>System;</t> SF-12; 12-item Short Form Health Survey; TS, total symptoms; ZBI, Zarit Burden Interview.
Patient Reported Outcomes Measurement Information System Fatigue Short Form 7a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fatigue+short+form+7a/promis+f+sf+7a/pmc12066461-82-16-15
Average 90 stars, based on 1 article reviews
patient-reported outcomes measurement information system fatigue short form 7a - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
ProMIS Neurosciences patient-reported outcomes measurement information system short form v1.0-fatigue 7a
Items included in the (A) patient and (B) caregiver models. CS, clinical summary; HADS-A, Hospital Anxiety and Depression Scale anxiety; HADS-D, Hospital Anxiety and Depression Scale depression; KCCQ, Kansas City Cardiomyopathy Questionnaire; MCS, mental component summary; NYHA, New York Heart Association; OS, overall summary; PCS, physical component summary; PROMIS, Patient-Reported <t>Outcomes</t> <t>Measurement</t> <t>Information</t> <t>System;</t> SF-12; 12-item Short Form Health Survey; TS, total symptoms; ZBI, Zarit Burden Interview.
Patient Reported Outcomes Measurement Information System Short Form V1.0 Fatigue 7a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fatigue+short+form+7a/promis+f+sf+7a/pm40198465-29-6-14
Average 90 stars, based on 1 article reviews
patient-reported outcomes measurement information system short form v1.0-fatigue 7a - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
ProMIS Neurosciences patient‐reported outcomes measurement information system short form v1.0‐fatigue 7a (promis f sf‐7a)
Items included in the (A) patient and (B) caregiver models. CS, clinical summary; HADS-A, Hospital Anxiety and Depression Scale anxiety; HADS-D, Hospital Anxiety and Depression Scale depression; KCCQ, Kansas City Cardiomyopathy Questionnaire; MCS, mental component summary; NYHA, New York Heart Association; OS, overall summary; PCS, physical component summary; PROMIS, Patient-Reported <t>Outcomes</t> <t>Measurement</t> <t>Information</t> <t>System;</t> SF-12; 12-item Short Form Health Survey; TS, total symptoms; ZBI, Zarit Burden Interview.
Patient‐Reported Outcomes Measurement Information System Short Form V1.0‐Fatigue 7a (Promis F Sf‐7a), supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fatigue+short+form+7a/promis+f+sf+7a/pm40198465-0-29-37
Average 90 stars, based on 1 article reviews
patient‐reported outcomes measurement information system short form v1.0‐fatigue 7a (promis f sf‐7a) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
ProMIS Neurosciences fatigue short form 7a
Items included in the (A) patient and (B) caregiver models. CS, clinical summary; HADS-A, Hospital Anxiety and Depression Scale anxiety; HADS-D, Hospital Anxiety and Depression Scale depression; KCCQ, Kansas City Cardiomyopathy Questionnaire; MCS, mental component summary; NYHA, New York Heart Association; OS, overall summary; PCS, physical component summary; PROMIS, Patient-Reported <t>Outcomes</t> <t>Measurement</t> <t>Information</t> <t>System;</t> SF-12; 12-item Short Form Health Survey; TS, total symptoms; ZBI, Zarit Burden Interview.
Fatigue Short Form 7a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fatigue+short+form+7a/fatigue+short+form+7a/us12258393-633-11-10
Average 90 stars, based on 1 article reviews
fatigue short form 7a - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Items included in the (A) patient and (B) caregiver models. CS, clinical summary; HADS-A, Hospital Anxiety and Depression Scale anxiety; HADS-D, Hospital Anxiety and Depression Scale depression; KCCQ, Kansas City Cardiomyopathy Questionnaire; MCS, mental component summary; NYHA, New York Heart Association; OS, overall summary; PCS, physical component summary; PROMIS, Patient-Reported Outcomes Measurement Information System; SF-12; 12-item Short Form Health Survey; TS, total symptoms; ZBI, Zarit Burden Interview.

Journal: Frontiers in Cardiovascular Medicine

Article Title: Predictors of disease burden in patients with untreated transthyretin amyloid cardiomyopathy and their caregivers: a post hoc analysis of an international survey

doi: 10.3389/fcvm.2025.1595797

Figure Lengend Snippet: Items included in the (A) patient and (B) caregiver models. CS, clinical summary; HADS-A, Hospital Anxiety and Depression Scale anxiety; HADS-D, Hospital Anxiety and Depression Scale depression; KCCQ, Kansas City Cardiomyopathy Questionnaire; MCS, mental component summary; NYHA, New York Heart Association; OS, overall summary; PCS, physical component summary; PROMIS, Patient-Reported Outcomes Measurement Information System; SF-12; 12-item Short Form Health Survey; TS, total symptoms; ZBI, Zarit Burden Interview.

Article Snippet: Of these, the patient-reported survey responses were used to calculate their out-of-pocket expenses; 23-item Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary (OS), Clinical Summary (CS), and Total Symptoms (TS) scores ( ); Hospital Anxiety and Depression Scale depression (HADS-D) and anxiety (HADS-A) subscale scores ( ); 12-item Short Form Health Survey (SF-12) V2 Physical Component Summary (PCS) and Mental Component Summary (MCS) scores ( – ); and Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Severity Short Form 7a V1.0 score ( , ).

Techniques:

Optimized models for the predictors of patient burden. Each figure shows the regression coefficient with 95% confidence interval. * P < 0.05. CS, clinical summary; HADS-A, Hospital and Depression Scale anxiety; HADS-D, Hospital Anxiety and Depression Scale depression; KCCQ, Kansas City Cardiomyopathy Questionnaire; MCS, mental component summary; NYHA, New York Heart Association; OS, overall summary; PCS, physical component summary; PROMIS, Patient-Reported Outcomes Measurement Information System; SF-12; 12-item Short Form Health Survey; TS, total symptoms.

Journal: Frontiers in Cardiovascular Medicine

Article Title: Predictors of disease burden in patients with untreated transthyretin amyloid cardiomyopathy and their caregivers: a post hoc analysis of an international survey

doi: 10.3389/fcvm.2025.1595797

Figure Lengend Snippet: Optimized models for the predictors of patient burden. Each figure shows the regression coefficient with 95% confidence interval. * P < 0.05. CS, clinical summary; HADS-A, Hospital and Depression Scale anxiety; HADS-D, Hospital Anxiety and Depression Scale depression; KCCQ, Kansas City Cardiomyopathy Questionnaire; MCS, mental component summary; NYHA, New York Heart Association; OS, overall summary; PCS, physical component summary; PROMIS, Patient-Reported Outcomes Measurement Information System; SF-12; 12-item Short Form Health Survey; TS, total symptoms.

Article Snippet: Of these, the patient-reported survey responses were used to calculate their out-of-pocket expenses; 23-item Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary (OS), Clinical Summary (CS), and Total Symptoms (TS) scores ( ); Hospital Anxiety and Depression Scale depression (HADS-D) and anxiety (HADS-A) subscale scores ( ); 12-item Short Form Health Survey (SF-12) V2 Physical Component Summary (PCS) and Mental Component Summary (MCS) scores ( – ); and Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Severity Short Form 7a V1.0 score ( , ).

Techniques: